APO-METHYLPHENIDATE ER
APOTEX INC
Quick answers
Is there a shortage of APO-METHYLPHENIDATE ER in Canada?
No. There is no current shortage of APO-METHYLPHENIDATE ER 54MG reported to Health Canada. Stock can still vary from one pharmacy to another.
ADHD Medication Shortage in Canada: What to Know
Why ADHD medications go into shortage in Canada more often than most drug classes, which ones are most affected, and what to do if yours is short-supplied.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
Other Products
PMS-METHYLPHENIDATE
PHARMASCIENCE INC
APO-METHYLPHENIDATE
APOTEX INC
AA-METHYLPHENIDATE SR
Extended-ReleaseAA PHARMA INC
BIPHENTIN
ELVIUM LIFE SCIENCES
FOQUEST
ELVIUM LIFE SCIENCES
DIN
02330377
Strength
54MG
Dosage Form
TABLET (EXTENDED-RELEASE)
Route
ORAL
Compare with another product →
Product Monograph
Product monograph is not available from Health Canada
Shortage History
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554178
2MG · DIN 02554194